Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial
Latest Information Update: 22 Jul 2024
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Capecitabine
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Feb 2023 Status changed from recruiting to discontinued.
- 28 Nov 2019 New trial record